Gentis news

GENTIS demonstrates its commitment to community responsibility through the journey of a french director searching for his birth mother in Vietnam

On May 21, 2025, a heartwarming story came to a close with an emotional reunion hug after 31 years of separation: French-Vietnamese filmmaker Arthur Chareire found his biological mother, Ms. Nguyễn Thị Hợi, in Vietnam. This miraculous journey was not only the result of Arthur's determination to reconnect with his roots, but also thanks to a silent yet pivotal factor: the support of GENTIS — a pioneer in genetics that facilitated the DNA testing between Arthur and his mother. GENTIS’s involvement in this journey is a clear testament to the company’s commitment to community responsibility — one of the core values it has always upheld and pursued.

GENTIS Accompanies the 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An in 2025

The 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An in 2025 is a significant scientific event in the field of reproductive health, organized by the Nghe An Obstetrics and Pediatrics Hospital. This is not only an important event for medical professionals but also a memorable milestone marking the 40-year development journey of Nghe An Obstetrics and Pediatrics Hospital (June 1, 1985 – June 1, 2025). It is a valuable opportunity for learning and also an occasion for GENTIS to demonstrate its commitment to the sustainable development of Vietnam’s healthcare sector.

GENTIS accompanies the ART ADVANCED 12 Conference: “New perspectives on reproductive science: from clinical data to personalized treatment”

The ART ADVANCED 12 conference is a significant scientific event in the field of reproductive support organized by the Hanoi Reproductive Support Association. With the theme “New Perspectives on Reproductive Science: From Clinical Data to Personalized Treatment,” the conference will provide in-depth updates and important discussions about advances in reproductive support. This is an opportunity for experts to meet, share experiences, and move towards personalized treatment to improve clinical practice outcomes.

GENTIS honored at the Vietnam's Number 1 Brand 2025 announcement ceremony

At the Vietnam’s Number 1 Brand 2025 announcement ceremony organized by the Asian Business Development Research Center, Genetic Analysis Services Joint Stock Company (GENTIS) was honored with the “Vietnam’s Number 1 Brand 2025” award in the genetic analysis field - Gold category, as well as the “Best Medical Product/Service for Consumers in 2025” award for the PGT-Max 1 test.

GENTIS collaborates with the Department of Andrology and Sexology - Hanoi University of Medicine to organize a scientific seminar

Recently, GENTIS collaborated with the Department of Andrology and Sexology at Hanoi University of Medicine to successfully organize a scientific seminar aimed at helping doctors and healthcare staff gain a better understanding of two specialized test packages: Whole Exome Sequencing (WES) and Sperm DNA Fragmentation.

"Happy Motherhood Journey" Prenatal Class - Equipping Expectant Mothers with Useful Knowledge

Recently, the 5th-floor hall of Hanoi Andrology and Fertility Hospital collaborated with the Happy Home AF HANOI Association successfully chaired the “Happy Motherhood Journey” prenatal class. GENTIS was honored to accompany the event as a sponsor.

Application of PGT-M tests in Thalassemia genetic disorder screening

Thalassemia is a recessive inherited anemia disorder on the autosomal chromosome, with the highest incidence rates globally, including in Vietnam. Thalassemia causes severe consequences for the material and mental well-being of affected individuals and their families. Currently, there is no definitive cure for this disease, but proactive prevention and screening are possible. Notably, the advent of Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) helps reduce the risk of having children affected by Thalassemia.

PGT-M for 100+ Rare Diseases: A Solution for Healthy Babies in Families Carrying Genetic Disorders

Rare diseases often lead to serious health complications and significantly affect a patient’s quality of life. Therefore, the development of PGT-M testing to screen and select embryos free of rare disease-causing genes for implantation is essential. In an effort to eliminate the fear of rare diseases from the community, GENTIS has researched and developed a PGT-M test capable of screening for over 100 rare diseases.